Page last updated: 2024-11-11
xanthofulvin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
xanthofulvin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 9894470 |
| SCHEMBL ID | 14003798 |
| MeSH ID | M0454775 |
Synonyms (10)
| Synonym |
|---|
| SCHEMBL14003798 |
| 151466-15-8 |
| xanthofulvin |
| 5-acetyl-7-[(z)-(5-carboxy-6,7-dihydroxy-4-oxochromen-3-ylidene)-hydroxymethyl]-2,3-dihydroxy-6-methyl-9-oxoxanthene-1-carboxylic acid |
| 5-acetyl-7-((5-carboxy-6,7-dihydroxy-4-oxo-2h-1-benzopyran-3(4h)-ylidene)hydroxymethyl)-2,3-dihydroxy-6-methyl-9-oxo-9h-xanthene-1-carboxylic acid |
| 32kp529uk8 , |
| spf 3059-1 |
| unii-32kp529uk8 |
| 9h-xanthene-1-carboxylic acid, 5-acetyl-7-((5-carboxy-6,7-dihydroxy-4-oxo-2h-1-benzopyran-3(4h)-ylidene)hydroxymethyl)-2,3-dihydroxy-6-methyl-9-oxo- |
| sm 216289 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 17.55
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (17.55) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (14.29%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (85.71%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||